# Top 50 Pharma Startups Worldwide by Funding (2026)

> The 50 best-funded pharma startups worldwide, ranked by total funding raised: $24B combined. With founding year, headquarters and each company's rounds.

Source: https://millionrounds.com/top-lists/pharma-startups (Millionrounds; every figure on the page links to its filing or article)

- 1 [**Altos Labs** Altos Labs focuses on cellular rejuvenation programming to restore cell health and resilience, to reverse disease to transform medicine.](https://millionrounds.com/company/altos-labs) Altos Labs focuses on cellular rejuvenation programming to restore cell health and resilience, to reverse disease to transform medicine. *Founded* 2021 San Francisco, United States **$3.0B** last round Sept 2021
- 2 [**National Resilience**](https://millionrounds.com/company/national-resilience) *Founded* 2020 United States **$1.6B** last round Jul 2026
- 3 [**Retro Biosciences** Retro Biosciences is a biotechnology company based in Redwood City, California, founded in May 2021.](https://millionrounds.com/company/retro-biosciences) Retro Biosciences is a biotechnology company based in Redwood City, California, founded in May 2021. *Founded* 2021 Redwood City, United States **$1.2B** last round May 2026
- 4 [**Resilience** Resilience is a cyber risk company based in San Francisco, founded in 2016 by experts from military intelligence, insurance, and technology.](https://millionrounds.com/company/resilience) Resilience is a cyber risk company based in San Francisco, founded in 2016 by experts from military intelligence, insurance, and technology. *Founded* 2016 New York, United States **$860M** last round Oct 2025
- 5 [**Mineralys Therapeutics** Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.](https://millionrounds.com/company/mineralys-therapeutics) Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension. *Founded* 2019 Radnor, United States **$788M** last round Jun 2026
- 6 [**Dianthus Therapeutics** Dianthus Therapeutics is a biotech company developing new treatments for serious autoimmune diseases using a more targeted approach.](https://millionrounds.com/company/dianthus-therapeutics) Dianthus Therapeutics is a biotech company developing new treatments for serious autoimmune diseases using a more targeted approach. *Founded* 2019 Waltham, United States **$719M** last round Mar 2026
- 7 [**ADC Therapeutics** ADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products.](https://millionrounds.com/company/adc-therapeutics) ADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products. *Founded* 2011 Lausanne, Switzerland **$646M** last round Oct 2026
- 8 [**Vaxcyte** Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.](https://millionrounds.com/company/vaxcyte) Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide. *Founded* 2013 San Carlos, United States **$633M** last round Jan 2026
- 9 [**Axsome Therapeutics** Axsome Therapeutics is a biopharmaceutical company that develops therapies for the management and treatment of neurological disorders.](https://millionrounds.com/company/axsome-therapeutics) Axsome Therapeutics is a biopharmaceutical company that develops therapies for the management and treatment of neurological disorders. *Founded* 2012 New York, United States **$577M** last round May 2025
- 10 [**CRISPR THERAPEUTICS** CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.](https://millionrounds.com/company/crispr-therapeutics) CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform. *Founded* 2014 United States **$550M** last round Mar 2026
- 11 [**Immunovant** Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases.](https://millionrounds.com/company/immunovant) Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases. *Founded* 2018 New York, United States **$550M** last round Dec 2025
- 12 [**Korsana Biosciences** Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.](https://millionrounds.com/company/korsana-biosciences) Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s. *Founded* - Waltham, United States **$530M** last round Sept 2026
- 13 [**CellCentric** CellCentric is a clinical-stage biopharmaceutical company based in Cambridge, UK.](https://millionrounds.com/company/cellcentric) CellCentric is a clinical-stage biopharmaceutical company based in Cambridge, UK. *Founded* 2004 Saffron Walden, United Kingdom **$525M** last round May 2026
- 14 [**MapLight Therapeutics** MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.](https://millionrounds.com/company/maplight-therapeutics) MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders. *Founded* 2018 Palo Alto, United States **$523M** last round Aug 2026
- 15 [**OMass Therapeutics** OMass Therapeutics is a biotechnology company located in Oxford, UK, focused on discovering and developing novel small molecule medicines for rare diseases and](https://millionrounds.com/company/omass-therapeutics) OMass Therapeutics is a biotechnology company located in Oxford, UK, focused on discovering and developing novel small molecule medicines for rare diseases and *Founded* 2016 Oxford, United Kingdom **$442M** last round Oct 2026
- 16 [**Ollin Biosciences** Ollin Biosciences is a clinical-stage biopharmaceutical company based in Austin, Texas, founded in 2023.](https://millionrounds.com/company/ollin-biosciences) Ollin Biosciences is a clinical-stage biopharmaceutical company based in Austin, Texas, founded in 2023. *Founded* - Austin, United States **$430M** last round Jun 2026
- 17 [**Remedi SeniorCare** Remedi SeniorCare provides pharmacy services by offering automatic therapeutic interchange education and consulting and transition services.](https://millionrounds.com/company/remedi-seniorcare) Remedi SeniorCare provides pharmacy services by offering automatic therapeutic interchange education and consulting and transition services. *Founded* 1954 Baltimore, United States **$430M** last round Aug 2013
- 18 [**Arcus Biosciences** Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.](https://millionrounds.com/company/arcus-biosciences) Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer. *Founded* 2015 Hayward, United States **$427M** last round Oct 2025
- 19 [**Zenas BioPharma** Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.](https://millionrounds.com/company/zenas-biopharma) Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients. *Founded* 2023 Waltham, United States **$420M** last round Mar 2026
- 20 [**SpringWorks Therapeutics** SpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer.](https://millionrounds.com/company/springworks-therapeutics) SpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer. *Founded* 2017 Stamford, United States **$400M** last round Dec 2023
- 21 [**Parabilis Medicines** Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.](https://millionrounds.com/company/parabilis-medicines) Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines. *Founded* - Cambridge, United States **$380M** last round Jun 2026
- 22 [**Autolus** Autolus is a biopharmaceutical company focused on T-cell programming and manufacturing technology.](https://millionrounds.com/company/autolus) Autolus is a biopharmaceutical company focused on T-cell programming and manufacturing technology. *Founded* - London, United Kingdom **$350M** last round Feb 2024
- 23 [**Madrigal Pharmaceuticals** Madrigal Pharmaceuticals is a biopharmaceutical company developing therapeutics for the treatment of cardiovascular-metabolic diseases.](https://millionrounds.com/company/madrigal-pharmaceuticals) Madrigal Pharmaceuticals is a biopharmaceutical company developing therapeutics for the treatment of cardiovascular-metabolic diseases. *Founded* 2011 Conshohocken, United States **$350M** last round Jul 2025
- 24 [**89Bio** 89bio is a biopharmaceutical company that develops clinical-stage therapies for liver and cardiometabolic diseases.](https://millionrounds.com/company/89bio) 89bio is a biopharmaceutical company that develops clinical-stage therapies for liver and cardiometabolic diseases. *Founded* 2018 San Francisco, United States **$348M** last round Jan 2025
- 25 [**New Path Molecular Research** NPM is all about bringing the best and most innovative chemistry to their product discovery projects and collaborations.](https://millionrounds.com/company/new-path-molecular-research) NPM is all about bringing the best and most innovative chemistry to their product discovery projects and collaborations. *Founded* 2015 United Kingdom **$346M** last round Aug 2025
- 26 [**Crystalys Therapeutics**](https://millionrounds.com/company/crystalys-therapeutics) *Founded* - United States **$335M** last round Jul 2026
- 27 [**NGM Biopharmaceuticals** NGM Biopharmaceuticals Inc.](https://millionrounds.com/company/ngm-biopharmaceuticals) NGM Biopharmaceuticals Inc. *Founded* 2008 South San Francisco, United States **$333M** last round Mar 2015
- 28 [**eGenesis**](https://millionrounds.com/company/egenesis) *Founded* - United States **$329M** last round Sept 2024
- 29 [**Haihe Biopharma** Haihe Biopharma is a biopharmaceutical company that develops cancer anti-tumour drugs.](https://millionrounds.com/company/haihe-biopharma) Haihe Biopharma is a biopharmaceutical company that develops cancer anti-tumour drugs. *Founded* 2011 China **$317M** last round Jul 2020
- 30 [**Corvus Pharmaceuticals** Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.](https://millionrounds.com/company/corvus-pharmaceuticals) Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company. *Founded* 2014 Burlingame, United States **$310M** last round Jan 2026
- 31 [**Maze Therapeutics** Maze Therapeutics is an operator of a biotechnology firm used to focus on translating genetic insights into new medicines.](https://millionrounds.com/company/maze-therapeutics) Maze Therapeutics is an operator of a biotechnology firm used to focus on translating genetic insights into new medicines. *Founded* 2018 South San Francisco, United States **$300M** last round Apr 2026
- 32 [**Beeline Medicines** Beeline Medicines is a clinical-stage biotechnology company based in Boston, Massachusetts, focused on developing precision therapies for autoimmune and inflamm](https://millionrounds.com/company/beeline-medicines) Beeline Medicines is a clinical-stage biotechnology company based in Boston, Massachusetts, focused on developing precision therapies for autoimmune and inflamm *Founded* 2025 Stamford, United States **$300M** last round Apr 2026
- 33 [**ACELYRIN** ACELYRIN is a biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies.](https://millionrounds.com/company/acelyrin) ACELYRIN is a biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies. *Founded* 2020 Los Angeles, United States **$300M** last round Sept 2022
- 34 [**Allakos** Allakos is a biotechnology company developing therapeutic antibodies targeting allergy, inflammatory and proliferative diseases.](https://millionrounds.com/company/allakos) Allakos is a biotechnology company developing therapeutic antibodies targeting allergy, inflammatory and proliferative diseases. *Founded* 2012 Redwood City, United States **$294M** last round Sept 2022
- 35 [**Arcellx** Arcellx is a clinical-stage biotechnology company focused on developing innovative immunotherapies for cancer and other incurable diseases.](https://millionrounds.com/company/arcellx) Arcellx is a clinical-stage biotechnology company focused on developing innovative immunotherapies for cancer and other incurable diseases. *Founded* 2015 Redwood City, United States **$285M** last round Nov 2023
- 36 [**Cullinan Therapeutics** Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.](https://millionrounds.com/company/cullinan-therapeutics) Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly. *Founded* - Cambridge, United States **$280M** last round Apr 2024
- 37 [**Mabwell Biotech** Mabwell Biotech is a Chinese innovative biopharmaceutical company.](https://millionrounds.com/company/mabwell-biotech) Mabwell Biotech is a Chinese innovative biopharmaceutical company. *Founded* 2017 Shanghai **$279M** last round Apr 2020
- 38 [**Evonetix** Evonetix is a provider of a desktop platform designed to synthesize DNA at unprecedented accuracy and scale.](https://millionrounds.com/company/evonetix) Evonetix is a provider of a desktop platform designed to synthesize DNA at unprecedented accuracy and scale. *Founded* 2015 Cambridge, United Kingdom **$276M** last round Jan 2025
- 39 [**Emalex Biosciences** Emalex Biosciences is a biotech startup that develops new treatments for central nervous system disorders.](https://millionrounds.com/company/emalex-biosciences) Emalex Biosciences is a biotech startup that develops new treatments for central nervous system disorders. *Founded* 2018 Chicago, United States **$270M** last round Nov 2022
- 40 [**GH Research** GH Research is a biopharmaceutical company developing novel therapies for the management of mental illness.](https://millionrounds.com/company/gh-research) GH Research is a biopharmaceutical company developing novel therapies for the management of mental illness. *Founded* 2018 Dublin, Ireland **$268M** last round Apr 2026
- 41 [**Inhibrx**](https://millionrounds.com/company/inhibrx) *Founded* 2017 United States **$265M** last round Mar 2026
- 42 [**Capital Rx** Capital Rx, now rebranded as Judi Health, is a prominent enterprise health technology company specializing in pharmacy benefits management (PBM).](https://millionrounds.com/company/capital-rx) Capital Rx, now rebranded as Judi Health, is a prominent enterprise health technology company specializing in pharmacy benefits management (PBM). *Founded* 2017 New York, United States **$264M** last round Sept 2025
- 43 [**Compass Therapeutics** Compass Therapeutics is a biopharmaceutical company that focuses on drugging the immune system to treat human diseases.](https://millionrounds.com/company/compass-therapeutics) Compass Therapeutics is a biopharmaceutical company that focuses on drugging the immune system to treat human diseases. *Founded* 2014 Boston, United States **$257M** last round Aug 2025
- 44 [**Aurinia Pharmaceuticals** Aurinia develops and commercializes therapies to treat targeted patient populations suffering from serious auto-immune diseases.](https://millionrounds.com/company/aurinia-pharmaceuticals) Aurinia develops and commercializes therapies to treat targeted patient populations suffering from serious auto-immune diseases. *Founded* - Victoria, Canada **$255M** last round Jun 2026
- 45 [**Kardigan** Kardigan is a heart health company developing drugs designed to make cardiovascular disease curable, preventable, and no longer the leading cause of death.](https://millionrounds.com/company/kardigan) Kardigan is a heart health company developing drugs designed to make cardiovascular disease curable, preventable, and no longer the leading cause of death. *Founded* 2023 Princeton, United States **$254M** last round Oct 2025
- 46 [**Anthos Therapeutics** Anthos Therapeutics is a biopharmaceutical company that specializes in the treatment of cardiovascular and metabolic diseases.](https://millionrounds.com/company/anthos-therapeutics) Anthos Therapeutics is a biopharmaceutical company that specializes in the treatment of cardiovascular and metabolic diseases. *Founded* 2018 Cambridge **$250M** last round Feb 2019
- 47 [**LB Pharmaceuticals** LB Pharmaceuticals specializes in developing a treatment for schizophrenia.](https://millionrounds.com/company/lb-pharmaceuticals) LB Pharmaceuticals specializes in developing a treatment for schizophrenia. *Founded* 2015 Menlo Park, United States **$250M** last round Jul 2026
- 48 [**ORIC Pharmaceuticals** ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.](https://millionrounds.com/company/oric-pharmaceuticals) ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance. *Founded* 2014 South San Francisco, United States **$248M** last round May 2025
- 49 [**Harmony Biosciences** Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.](https://millionrounds.com/company/harmony-biosciences) Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders. *Founded* 2017 Plymouth Meeting, United States **$248M** last round Oct 2024
- 50 [**Arcutis Biotherapeutics** Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing medical dermatology for unmet needs.](https://millionrounds.com/company/arcutis-biotherapeutics) Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing medical dermatology for unmet needs. *Founded* 2016 Westlake Village, United States **$245M** last round Feb 2024

**Total funding** how the list is ranked

**15 November 2026** updated nightly

**Rounds we track** source: Millionrounds

Companies whose funding rounds we classed as this sector, ranked by the total they have raised in rounds we hold. Nobody pays to be on a list.

## Who backed them?

Open any company for its rounds and investors, or search the investors who back pharma startups worldwide in the app, with filters, lists and exports.

[Find their investors](https://millionrounds.com/login?join=1&next=/app/investors)[All top lists](https://millionrounds.com/top-lists)

## More pharmaceutical lists

[See all](https://millionrounds.com/top-lists?t=Pharmaceutical)

[*AT* *C* *OT* **Pharma startups in Europe** 213 companies · $6.8B](https://millionrounds.com/top-lists/pharma-startups-europe)

## More lists worldwide

[See all](https://millionrounds.com/top-lists?r=Global)

[*GV* *V* *RP* **Health startups worldwide** 12,811 companies · $81B](https://millionrounds.com/top-lists/health-startups)[*O* *A* *X* **AI startups worldwide** 10,238 companies · $830B](https://millionrounds.com/top-lists/ai-startups)[*GV* *V* *RP* **Biotech startups worldwide** 7,127 companies · $70B](https://millionrounds.com/top-lists/biotech-startups)[*D* *B* *FT* **Big data startups worldwide** 3,812 companies · $220B](https://millionrounds.com/top-lists/big-data-startups)[*AF* *R* *S* **Fintech startups worldwide** 3,200 companies · $94B](https://millionrounds.com/top-lists/fintech-startups)[*O* *A* *B* **AI startups that raised in 2026** 2,922 companies · $540B in 2026](https://millionrounds.com/top-lists/ai-startups-raised-2026)[*FT* *CE* *P* **Energy providers startups worldwide** 2,808 companies · $152B](https://millionrounds.com/top-lists/energy-providers-startups)[*A* *P* *O* **Marketing tech startups worldwide** 2,728 companies · $28B](https://millionrounds.com/top-lists/marketing-tech-startups)